 |
 |
Micromuscle is an advanced materials company that develops electroactive polymer (EAP) technology for
the medical device markets. The Company holds strong IPR assets covering design,
manufacturing as well as use of EAP technology in specific medical applications. |
 |
 |
 |
 |
|
Electroactive polymers enable new, innovative medical devices e.g. for vascular applications.
 See Applications section. |
Joint Development combines the MICROMUSCLE EAP technology with partners' ideas and experience.
See the Partnering section. |
The MICROMUSCLE EAP technology enables new functionality for medical device applications.
See the Technology
section. |
Request information or ask questions about artificial muscles, EAP technology, etc.
See the Contact section.
|
|
|
|
LATEST NEWS
Creganna
- 17 October, 2008: All activities of Micromuscle are now managed by Creganna. For queries contact Alan Crean, Creganna on +353 91 757801. www.creganna.com
Royal visit at Micromuscle
- 17 April, 2008: H.M. King Carl XVI Gustaf, The Crown Princess Victoria and The Grand Duke of Luxembourg visited Micromuscle for a presentation of Micromuscle and EAP technology
New patents
- 8 January, 2008: Several new Micromuscle patents granted in US, EU and Japan. Read more
Joint development advances
- 4 April, 2007: Micromuscle has signed for the next phase in joint development with major medical device partner, read press release
All news in the News & Press section.
|
|
